# Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis

> **NCT00561639** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 76 (actual)

## Conditions studied

- Hematologic Diseases
- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00561639
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2010-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561639, "Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00561639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*